BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6849714)

  • 1. Treatment of hypertension in acute stage of myocardial infarction. Haemodynamic effects of labetalol.
    Renard M; Rivière A; Jacobs P; Bernard R
    Br Heart J; 1983 Jun; 49(6):522-7. PubMed ID: 6849714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of labetalol on preload in acute myocardial infarction with systemic hypertension.
    Renard M; Jacobs P; Melot C; Haardt R; Vainsel H; Bernard R
    J Cardiovasc Pharmacol; 1984; 6(1):90-3. PubMed ID: 6199618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol infusion in acute myocardial infarction with systemic hypertension.
    Marx PG; Reid DS
    Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
    Verma SP; Silke B; Hussain M; Nelson GI; Wilson JA; Reynolds GW; Richmond A; Taylor SH
    J Hypertens; 1988 Nov; 6(11):897-904. PubMed ID: 2906956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of combined or separate alpha- and beta-blockade in the treatment of hypertension in the acute stage of myocardial infarction.
    Renard M; Jacobs P; Liebens I; Abou Hamdam B; Bernard R
    Int J Cardiol; 1986 Feb; 10(2):149-58. PubMed ID: 3080379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic dose-response effects of intravenous labetalol in acute myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():98-103. PubMed ID: 6647215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Labetalol for the management of hypertensive crises during surgery of cerebral aneurysm; a haemodynamic study (author's transl)].
    Lüben V; Rieder W; Zierski J; Hempelmann G
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):184-7. PubMed ID: 7294326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol infusion for the treatment of hypertension in acute myocardial infarction.
    Timmis AD; Fowler MB; Jaggarao NS; Chamberlain DA
    Eur Heart J; 1980 Dec; 1(6):413-6. PubMed ID: 7274255
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of labetalol on systemic and pulmonary haemodynamics at rest and during exercise in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Clin Sci Mol Med Suppl; 1978 Dec; 4():279s-281s. PubMed ID: 282068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of labetalol in acute myocardial infarction.
    Timmis AD; Fowler MB; Jaggarao NS; Vincent R; Chamberlain DA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):111S-114S. PubMed ID: 7093093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central inhibition of sympathetic overdrive by clonidine in acute myocardial infarction with systolic hypertension. Haemodynamic study.
    Renard M; Liebens I; Waterschoot P; Bernard R
    Angiology; 1986 Sep; 37(9):633-41. PubMed ID: 3767070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and haemodynamic studies with labetalol in acute myocardial infarction.
    Silke B; Nelson GI; Ahuja RC; Choudhury S; Taylor SH
    Ir J Med Sci; 1983 May; 152(5):179-86. PubMed ID: 6874287
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic effects of labetalol in patients with acute myocardial infarct and systemic arterial hypertension].
    Cantelli I; Lombardi G; Naccarella F; Pavesi PC; Bracchetti D
    G Ital Cardiol; 1981; 11(1):110-8. PubMed ID: 7239092
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term (six-year) hemodynamic effects of labetalol in essential hypertension.
    Lund-Johansen P
    Am J Med; 1983 Oct; 75(4A):24-31. PubMed ID: 6638038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
    Mehta J; Feldman RL; Marx JD; Kelly GA
    Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
    Condorelli M; Brevetti G; Chiariello M; Miceli D; Lavecchia G; Paudice G; Verrienti S
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):101S-110S. PubMed ID: 7093092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
    Joekes AM; Thompson FD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.